|Bid||42.84 x 200|
|Ask||43.90 x 200|
|Day's Range||42.25 - 44.24|
|52 Week Range||23.28 - 63.73|
|PE Ratio (TTM)||-18.15|
|Earnings Date||Jul 17, 2017 - Jul 21, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||66.29|
MercadoLibre stock has returned 75% year-to-date. Can you beat that? Let's try.
CAMBRIDGE, Mass., July 24, 2017-- Sarepta Therapeutics, Inc., a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment ...
Sarepta stock toed the line Monday after a three-day run turned negative following its strong second-quarter report last week and a price-target hike.